Donanemab, Ly3002813
Alzheimer Disease
Phase IV
Not Yet Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease
Sep 18, 2026
―
Oxaliplatin, Cetuximab, 5-Fluorouracil, Olomorasib, Leucovorin/Levofolinate Calcium, Ly3537982
Colorectal Neoplasms
Phase II
Not Yet Recruiting
A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation
Sep 04, 2026
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eli Lilly & Co (LLY) have in its pipeline
LLY is currently developing the following drugs: Florbetapir F18, Florbetaben F 18, Ly4560736, Donanemab, Ly3002813, Vepugratinib, Ly3866288. These drug candidates are in various stages of clinical development as the company works toward FDA approval.